Related Experiment Video
Updated: Jun 12, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI
K Kantarci1, R Avula, M L Senjem
1Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. kantarci.kejal@mayo.edu
Objective:
To identify the patterns of diffusivity changes in patients with dementia with Lewy bodies (DLB) and Alzheimer disease (AD) and to determine whether diffusion tensor MRI (DTI) is complementary to structural MRI in depicting the tissue abnormalities characteristic of DLB and AD.
Methods:
We studied clinically diagnosed age-, gender-, and education-matched subjects with DLB (n = 30), subjects with AD (n = 30), and cognitively normal (CN) subjects (n = 60) in a case-control study. DTI was performed at 3T with a fluid-attenuated inversion recovery-based DTI sequence that enabled cortical diffusion measurements. Mean diffusivity (MD) and gray matter (GM) density were measured from segmented cortical regions. Tract-based diffusivity was measured using color-coded fractional anisotropy (FA) maps.
Results:
Patients with DLB were characterized by elevated MD in the amygdala and decreased FA in the inferior longitudinal fasciculus (ILF). ILF diffusivity was associated with the presence of visual hallucinations (p = 0.007), and amygdala diffusivity was associated with Unified Parkinson's Disease Rating Scale (r = 0.50; p = 0.005) in DLB. In contrast, patients with AD were characterized by elevated MD in the medial temporal, temporal, and parietal lobe association cortices and decreased FA in the fornix, cingulum, and ILF. Amygdala diffusivity was complementary to GM density in discriminating DLB from CN; hippocampal and parahippocampal diffusivity was complementary to GM density in discriminating AD from CN.
Conclusion:
Increased amygdalar diffusivity in the absence of tissue loss in dementia with Lewy bodies (DLB) may be related to microvacuolation, a common pathology associated with Lewy body disease in the amygdala. Diffusivity measurements were complementary to structural MRI, demonstrating that measures of diffusivity on diffusion tensor MRI are valuable tools for characterizing the tissue abnormalities characteristic of Alzheimer disease and DLB.
Insights
Diffusion tensor MRI reveals distinct diffusivity patterns in dementia with Lewy bodies (DLB) and Alzheimer disease (AD). These diffusion measurements complement structural MRI, aiding in the characterization of tissue abnormalities in DLB and AD patients.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Dementia with Lewy bodies (DLB) and Alzheimer disease (AD) are distinct neurodegenerative conditions.
- Structural MRI is a standard tool for assessing tissue loss in these diseases.
- Diffusion tensor MRI (DTI) offers insights into white matter integrity and microstructural changes.
Purpose of the Study:
- To identify unique diffusivity patterns in DLB and AD using DTI.
- To assess if DTI complements structural MRI in differentiating DLB and AD.
- To correlate DTI findings with clinical symptoms and disease characteristics.
Main Methods:
- Case-control study comparing DLB (n=30), AD (n=30), and cognitively normal (CN) (n=60) subjects.
- 3T DTI with a FLAIR-based sequence for cortical diffusion measurements.
- Quantification of mean diffusivity (MD) in gray matter and fractional anisotropy (FA) in white matter tracts.
Main Results:
- DLB patients showed elevated amygdala MD and decreased inferior longitudinal fasciculus (ILF) FA, correlated with hallucinations and parkinsonism.
- AD patients exhibited elevated MD in medial temporal, temporal, and parietal cortices, with decreased FA in the fornix, cingulum, and ILF.
- Amygdala diffusivity distinguished DLB from CN; hippocampal/parahippocampal diffusivity distinguished AD from CN, complementing gray matter density.
Conclusions:
- Increased amygdalar diffusivity in DLB may indicate microvacuolation, a hallmark of Lewy body disease.
- DTI-derived diffusivity measurements are valuable for characterizing tissue abnormalities in AD and DLB.
- DTI serves as a complementary tool to structural MRI for diagnosing and differentiating neurodegenerative diseases.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson Disease ll: Pathophysiology
